Search - tctmd.com

Displaying 1 - 20 of 49

Sort: Relevancy | Date

News Daily News

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Caitlin E. Cox

December 12, 2017

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!

Presenter: Nick Hopkins, Aman B. Patel

November 01, 2017

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Presenter: Nick Hopkins, Aman B. Patel, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

Flash Debate 2: I Favor Conscious Sedation Over General Anesthesia in Acute Stroke!

Presenter: Nick Hopkins, Aman B. Patel, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Klaus D. Mathias

November 01, 2017

Presentation TCT 2017

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!

Presenter: Brian G. DeRubertis, D. Christopher Metzger, Christopher J. White

November 01, 2017

Presentation TCT 2017

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, Alfredo Trento

November 01, 2017

Presentation TCT 2017

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Presenter: Gilles Dreyfus, Sanjay Kaul, John G. Webb

November 01, 2017

Presentation TCT 2017

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Presenter: Gilles Dreyfus, Sanjay Kaul, Hendrik Treede

November 01, 2017

Presentation TCT 2017

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Presenter: Gilles Dreyfus, Sanjay Kaul, Raj Makkar

November 01, 2017

Presentation TCT 2017

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Duane S. Pinto

November 01, 2017

Presentation TCT 2017

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Presenter: Gilles Dreyfus, Sanjay Kaul, Samir R. Kapadia

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert-Jan van Geuns

November 01, 2017

Presentation TCT 2017

Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies!

Presenter: Sanjay Kaul, Tullio Palmerini, Robert A. Byrne

November 01, 2017

Presentation TCT 2017

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Jacek Legutko

November 01, 2017

Presentation TCT 2017

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Presenter: Sanjay Kaul, Tullio Palmerini, Evald H. Christiansen

November 01, 2017

Presentation TCT 2017

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Dimitri Karmpaliotis

November 01, 2017

Presentation TCT 2017

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Presenter: Sanjay Kaul, Tullio Palmerini, Holger Thiele

November 01, 2017

Presentation TCT 2017

Flash Debate: FFR/iFR in ACS Patients With MVD There is Little Credible Evidence on Which to Base Any Recommendations!

Presenter: Sanjay Kaul, Tullio Palmerini, Francesco Saia

November 01, 2017

Presentation TCT 2017

Flash Debate: FFR/iFR in ACS Patients With MVD - Based on the Evidence the Guidelines are Justified and Should Be Even Stronger!

Presenter: Sanjay Kaul, Tullio Palmerini, Tim P. van de Hoef

November 01, 2017

Advertisement

USPSTF Upholds Stance Against Hormone Therapy to Prevent Chronic Diseases in Menopausal Women

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Flash Debate 2: I Favor Conscious Sedation Over General Anesthesia in Acute Stroke!

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!

Flash Debate 1: Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!

Flash Debate: Surgery Remains the First Option in All Operable Patients With Bicuspid Aortic Stenosis!

Flash Debate: Enough Evidence Is Present to Justify TAVR in Select Patients With Bicuspid Aortic Stenosis!

Flash Debate: Surveillance and Prophylactic Treatment of Asymptomatic TAVR Thrombosis Is Not Currently Warranted!

Flash Debate: Valve Thrombosis After TAVR Is a Serious Concern That Deserves Detection and Management!

Flash Debate: Based on Clinical Studies, Embolic Protection Devices Should Infrequently Be Used During TAVR

Flash Debate: The Evidence and Clinical Need Justifies the Widespread Use of Embolic Protection During TAVR

Flash Debate: Bioresorbable Scaffolds Are Appropriate for Clinical Use in Suitable Patients With Optimal Technique!

Flash Debate: Bioresorbable Scaffolds Should Rarely be Used Outside of Carefully Controlled Research Studies!

Flash Debate: If Anything, Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should be Downgraded Based on EXCEL and NOBLE!

Flash Debate: Guideline Recommendations for PCI in Low-to-Intermediate Risk Left Main Disease Should Be Upgraded to Class I Based on EXCEL and NOBLE!

Flash Debate: Registry Data and Personal Experiences Are Strong Enough to Justify Frequent Use of IMPELLA in High-Risk PCI and Cardiogenic Shock!

Flash Debate: There Is Insufficient Evidence From Randomized Trials to Justify Frequent Use of Impella in High-Risk PCI and Cardiogenic Shock!

Flash Debate: FFR/iFR in ACS Patients With MVD There is Little Credible Evidence on Which to Base Any Recommendations!

Flash Debate: FFR/iFR in ACS Patients With MVD - Based on the Evidence the Guidelines are Justified and Should Be Even Stronger!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content